Treatment as Prevention: The Effect of HAART on Infectiousness Bernard Hirschel Division of Infectious Diseases Geneva University Hospital Geneva, Switzerland.

Slides:



Advertisements
Similar presentations
HIV treatment as prevention Stephen Kegg. 2 Learning Outcomes Overview of HIV management HIV transmission risks Current prevention strategies Which new.
Advertisements

HIV/AIDS Prevention and Treatment in Thailand
8th Grade Choosing the Best
Monica Gandhi MD, MPH Associate Professor and Women’s HIV Clinic provider, HIV/AIDS Division San Francisco General Hospital/ UCSF Safe Poz Love, U.S. Positive.
Section 22.4 Protecting Yourself From HIV and AIDS Objectives
The hidden HIV epidemic: what do mathematical models tell us? The case of France Virginie Supervie, Jacques Ndawinz & Dominique Costagliola U943 Inserm.
HIV in Texas: The Ways Forward Ann Robbins Manager of HIV/STD Prevention and Care Department of State Health Services.
TasP is not enough Stipulated that TasP is effective in reducing infectiousness of the treated person – But much more is required. TasP requires effective.
HIV/AIDS Major effects on women and children in developing countries.
Introduction to HIV Discordant Couple Insemination Deborah J. Anderson, Ph.D. Dept Medicine and Center for AIDS Research Harvard Medical School and Department.
Barebacking: A Harm Reduction Approach Paul Quick, M.D. Tom Waddell Health Center San Francisco Department of Public Health
The HIV/AIDS Epidemic © 2005 John B. Pryor Illinois State University.
Harvard University Initiative for Global Health Global Health Challenges Social Analysis 76: Lecture 7.
The HIV/AIDS Epidemic © 2001 John B. Pryor Illinois State University.
The HIV/AIDS Epidemic © 2005 John B. Pryor Illinois State University.
Are people living with HIV less likely to pass HIV to others if they are on treatment? Exploring the use of treatment as prevention James Wilton Project.
Female Condom: A Powerful Tool for Protection Journalist to Journalist Training XVI International AIDS Conference Toronto August 2006.
Am I affected by AIDS?.
The HIV/AIDS Epidemic © 2013 John B. Pryor Illinois State University.
Undetectable = Uninfectious ? Treatment as Prevention.
Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma Marcelin AG 1, Tubiana R 1, Lambert-Niclot.
Community viral load and newly reported HIV infections in Switzerland Matthias Egger Professor of Epidemiology & Public Health Institute of Social and.
HIV Basics. What is HIV? Human Immunodeficiency Virus ◦ Two Strains  HIV-1  HIV-2 Kills special blood cells that help fight off infections ◦ CD4+ Virus.
HIV/AIDS Presented by Kunphen center for substance dependence and HIV/AIDS.
SRH/HIV Linkages: What’s The Rationale? Ward Cates, MD, MPH Family Health International World Bank Washington, DC November 19, 2008.
FEEDBACK Living 2008 Summit & XVII International AIDS Conference Universal Action Now Mexico City August 2008 Silvia Petretti Community Development Manager.
LIMPOPO PROVINCIAL MEN’S SECTORS/BROTHERS FOR LIFE PRESENTED BY: RAPAKWANA JOHANNAH MANAGER:GAAP in HIV & AIDS & STIs Directorate DEPT OF HEALTH AND SOCIAL.
RESULTS METHODS Pre-exposure prophylaxis and timed intercourse for HIV-discordant couples willing to conceive a child P. Vernazza 1 I. Brenner 1, I. Graf.
The Effect of Syphilis Co-infection on Clinical Outcomes in HIV-Infected Persons The Effect of Syphilis Co-infection on Clinical Outcomes in HIV-Infected.
Context and Association of Meth Use and Sexual Risk Behavior David W. Purcell, JD, PhD Prevention Research Branch Division of HIV/AIDS Prevention, NCHHSTP,
Session 6 Objectives By the time we finish today, you will be able to: Name at least three ways HIV and other sexually transmitted diseases can be prevented.
1 Advantages and risks for a child to be exposed to the triple prophylaxis during pregnancy and breastfeeding What is the best for the child ? Pr C. Courpotin.
PMTCT: a moving target or a moving strategy? 23rd June 2008 MSF Access Campaign.
HIV i-Base: SMART Study & CROI Feedback UK-CAB - Feb 2006 UK-CAB 24 February 2006 CROI Feedback: SMART Study Simon Collins.
Looking back, looking forward: what we know and don’t know about oral PrEP and tenofovir gel for preventing HIV in women Jared Baeten MD PhD Departments.
 HIV/AIDS is the Human immunodeficiency virus/ acquired immunodeficiency syndrome  Is a disease of the human immune system caused by the infection of.
Implementation of HIV Treatment as Prevention in China Yan Zhao MD National Center for AIDS/STD Control & Prevention Chinese Center for Disease Control.
HIV-infected subjects with CD4 350 to 550 cells/mm serodiscordant couples HPTN 052 Study Design Immediate ART CD Delayed ART CD4
Sexually Transmitted Disease Prevention 101 Presented by Lora Lock RN and Tessa Dillon RN Nova Southeastern University.
Organization of African Unity Pandemic Report. 1. Denial of the Problem For many years, people denied that AIDS was a big problem. Particularly in the.
School: Shrimati Indira Gandhi SSS, Mauritius Age group: Form 4, yrs Subject: Art and Design.
Transmission of HIV from mother to fetus. - is not simply one of the major health problems today, but also a big problem in the field of human rights.
Global SRH/HIV Integration National HIV Prevention Conference “Integration of Services: National and International Perspectives” Atlanta, GA August 24,
Undetectable= Uninfectious? Community Response To “The Swiss Statement” Women’s perspective Silvia Petretti Positively Women, Community Development Manager.
Do this now: 1. pick up a handout from the front table. 2. Think: What do you know about AIDS? 3. No homework.
Risk of Sexual Transmission under HAART Background information on Swiss statement Pietro Vernazza President EKAF- Swiss Federal Commission on AIDS.
HIV/AIDS IN AFRICA- "The Orphaned Continent"
Dan Dougherty and Allie Capetola Period 5.  Human immunodeficiency virus  Leads to AIDS (Acquired immunodeficiency syndrome)  HIV is spread through.
HOPE YOU ARE HAVING A GREAT WEEK! What is something new you have learned?
HIV/AIDS Safe Sex Is The Best Sex By Myeisha Myles.
Antiretrovirals for HIV Prevention: Progress and Challenges Kenneth H. Mayer, M.D. Brown/Miriam/Fenway.
What are HIV and AIDS? Human immunodeficiency virus (HIV) is a virus that destroys the immune system. The main target of HIV are CD4 cells, or helperT.
New Developments in HIV Kerri Howley Coordinator – The Green Room
HIV in India David S. Hausner American Embassy School 8 th Grade Population Project 24 February 2012.
Ceri Evans Senior Sexual Health Adviser West London Centre for Sexual Health Chelsea and Westminster Hospital Foundation Trust.
Intro to HIV/AIDS for Gifted Hands Volunteers Jennifer Samuels, MPH AIDS Service Center NYC
HIV Prevention: A Winnable Battle Centers for Disease Control and Prevention.
HIV and AIDS Quiz ANSWERS A Strategic Planning Session for Parliamentary Select Committees on HIV/AIDS and the Social Cluster Portfolio Committee. Maseru,
Provider Initiated HIV Counseling and Testing Unit 1: Introduction to HIV/AIDS.
PrEP Facts Clinical trials have shown daily oral Tenofovir to effectively prevent HIV acquisition PrEP must only be prescribed for HIV- patients and patients.
Module 4 (e) Pregnancy and Breast Feeding
Issues in considering the relevance of male circumcision to prevent HIV in Barbados Caroline Allen.
Dual Protection = prevent pregnancy + avoid STI/HIV
David Magnuson, Trevor Hawkins, Robertino Mera
100 Partners PrEP[5] Efficacy 75% Adherence 81% 80
HIV.
Management of HIV/AIDS
U=U Guidance for Implementation in Clinical Settings
Undetectable = Untransmittable
Presentation transcript:

Treatment as Prevention: The Effect of HAART on Infectiousness Bernard Hirschel Division of Infectious Diseases Geneva University Hospital Geneva, Switzerland

Prevention at an Impasse Sexual behaviour Condoms Circumcision Vaccine Microbicides

HIV Prevention Tools - Infection Rates (Source: W. Cates) Oral Acyclovir Percent of Persons Infected after a Decade of Use Rate during typical use Rate during perfect use Male circumcision Vaccines Microbicides Diaphragm Male condom Oral ARV Female condom Abstinence

HAART: potentially more efficacious

AllMen-WomenWomen-Men « Rakai » Study: Transmission risk as a function of viral load No transmission if VL « undetectable » Quinn et al. N Engl J Med 2000;342:921-9

N Engl J Med 1999;341: Maternal levels of plasma HIV RNA and the risk of perinatal transmission No transmission if maternal viremia < 1000/ml Mother’s viremia of a non infected new born Mother’s viremia of an infected new born

Mother to Child Transmission AZT HAART % of infected children

Effect of HAART on MTCT 2500 babies born to HIV+ mothers with undetectable viral load at > 36 weeks 3 neonatal infections Claire Townsend et al. 15th CROI, Poster 653

Effects of HAART on heterosexual transmission 393 heterosexual couples in Madrid The index patient was HIV +, first consulted The partners’ only risk factor for HIV acquisition was exposure to the index patient All partners were HIV-tested Castilla, et al. JAIDS 2005; 40:96-101

Prevalence of HIV infection in the partners Pre-HAARTHAART Pourcent des partenaires infecté(e)s

Castilla, et al. JAIDS 2005; 40: « HAART versus condoms » Infection rates in sex partners Ttmt of the index pt No ttmt Mono- ou bitherapy HAART Unsafe sex >1/month<1/moNever % %

Condoms plus HAART in comparison to condoms alone: 2 African studies What they had in common: Transmission in Uganda Sero-discordant Couples Condom Promotion How they differed: Study A*, without HAART, evaluated the effect of circumcision on male-to-female transmission Study B**, with HAART, evaluated transmission both ways * Wawer M et al. Abstract 33 LB, 15th CROI, Boston 2008 **Bunnell R et al. Abstract 29, 15th CROI, Boston 2008

Results Study A*Study B** Condoms HAART- N infections observed12% ppy0.5 % ppy 95% CI9 – * Wawer M et al. Abstract 33 LB, 15th CROI, Boston 2008 **Bunnell R et al. Abstract 29, 15th CROI, Boston 2008, AIDS 2006

Rwanda Follow-up of 1034 sero-discordant couples; in 248 the infected partner was on HAART In spite of condom promotion, 42 incident infections were observed HAARTNo HAART N total Seroconversions240 Per cent * Kayitenkore K et al. 14th International AIDS Conference Toronto 2006, abstract no. MOKC101

In conclusion HAART lowers MTCT HAART lowers heterosexual transmission (no data on male homosexual transmission) In Africa and in Europe, HAART appears more effective than condoms, in sero-discordant heterosexual couples

Contents Without treatment: Relation between viremia and contagiousness Haart: Effects on viremia and contagiousness For the individual: Conclusions to draw (or not) –The Match-up: HAART versus condoms –The problematic « zero risk » –Condoms always, except… –Procreation and PEP –The $ question The epidemic: possible consequences Background to the “Swiss Statement ”

Let’s assume, hypothetically: –Patient A is on HAART, BLD, since 2001 –Meets patient B in 2002, who is HIV- –Patient B is still HIV- in 2004, but HIV+ in 2005 –The viruses of A and B are closely related –A and B claim to have no other sex partners Possible interpretations: 1)A infected B despite having viremia BLD 2)A infected B during a treatment interruption 3)A third individual, C, infected both A and B Zero-Risk-Problem (4):

Conclusions Interpretation of rare cases of transmission depends on what people tell you about their sex lives For an enjoyable discussion, see: Lewontin RC: Sex, Lies, and Social Science The New York Review of Books, Volume 42, Number 7, April 20, 1995 A difficult basis for public health decisions… Zero-Risk-Problem (5):

Contents Without treatment: Relation between viremia and contagiousness Haart: Effects on viremia and contagiousness For the individual: Conclusions to draw (or not) –The problematic zero risk –Condoms always, except… Procreation and PEP The $ question The epidemic: possible consequences Background to the “Swiss Statement ”

Condoms, except…. Both partners are infected –The principal reason to use condoms (prevention of new infections) has disapeared. –Secondary reasons which speak for condoms anyway The simplicity of the message: 100% condoms Contraception, protection against other STI Superinfection: A more virulant or more resistant HIV strain supposedly replaces a « gentler » HIV: –Theoretical construct that has never been proven. (AIDS 2003;17:F11: A patient with resistant virus is superinfected with a more sensitive virus…) –Does not apply if both partners are infected and treated, with undetectable viremia.

Condoms except… Desire for procreation In vitro fertilisation (IVF) –Spermatozoa contain little or no HIV, even without treatment –One can separate spermatozoa from other sperm constituents by centrifugation Arguments against –Expensive, unavailable in poor countries –Success rate of only 15% (compared to natural pregnancy rates of approximately 50% after 6 mos) –Ovarian stimulation is necessary, producing high incidence of multiple pregnancies –No virus – no risk? IVF: A solution for a non-existant problem?

Natural conception in sero- discordant couples 62 couples Infected partners with undetectable viremia Non-protected sex, in principal only during fertile days 78 pregnancies at term No HIV transmission Barreiro P et al. Natural Pregnancies in HIV-Serodiscordant Couples Receiving Successful Antiretroviral Therapy. J Acquir Immune Defic Syndr 2006;43:324–326.

Contents Without treatment: Relation between viremia and contagiousness Haart: Effects on viremia and contagiousness For the individual: Conclusions to draw (or not) The epidemic: possible consequences –The other side of the coin: desinhibition –Syphilis and HIV compared: the dog that did not bark –If one treated everybody ? –Without vaccination… Background to the “Swiss Statement ”

Trends in Primary and Secondary Syphilis and HIV Seroincidence among Men Who Have Sex with Men in San Francisco, Buchacz, J Klausner et al. CDC, Atlanta, GA, USA, CROI 2005, Presentation # 88 The Dog that Didn’t Bark

How to explain the divergence between these two, when one knows that more than 50% of those with syphilis were co-infected with HIV?

If HAART did not lower transmission All other things being equal, the number of new infections would increase, because: -Infected persons survive thanks to treatment and stay sexually active -The non-infected, being less afraid of AIDS, drop their precautions Even today, in places like Amsterdam and Vancouver, HAART prevents at least half of all new HIV infections

Directed at physicians, to help in counselling Concluded that the risk of sex on HAART without condoms was « close to zero », less than the risk of sex off HAART with condoms Tightly qualified: –On HAART for at least six months –Consistently undetectable VL –No STDs –Perfect adherence Swiss statement does not –Advise against condoms –Condone unsafe sex Statement of the Swiss Federal AIDS Commission (January 2008)

If HAART lowers contagiousness, then Why talk about it ?

(1) Discrimination Based on fear (of contamination) Particularly in African women Patients who hesitate to touch or kiss their children and grandchildren « A load off their backs »

Cela fait des années que nous attendons avec impatience un tel document. Il enlève un poids à celles qui sont infectées par le virus, et qui craignent plus que tout être à l’origine d’une nouvelle contamination. Cette crainte contribue à notre isolement. Connaissant l’effet préventif du traitement bien conduit, nous serons doublement motivées à prendre nos pilules (..) et nous lutterons avec une détermination renouvelée contre les discriminations dont nous faisons l’objet. Lucy Serena* 28 novembre 2007 For years we have been impatiently waiting for such a statement. It takes a load off those who are infected with the virus, and who fear, more than anything, to be the source of a new infection. This fear increases our isolation. Knowing the preventive effect of treatment we will be doubly motivated to take our pills (…) and will fight with newfound resolve against discrimination and stigma. * Chairwoman of ASFAG, a self-help organisation of African women with HIV/AIDS based in Geneva

(2) Lawsuits Men accused of endangering others through unprotected sex (although no transmssion took place) Defending themselves saying that due to HAART and undetectable viral load, they were non-infectious Comdemned (to prison terms) anyway because official documents state the opposite

(3) Conception See above

(4) PEP In case of sexual contact with a person whose VL is undetectable, consider the numbers: –Probability of transmission (less than) 1/10’000 –Cost of PEP approx 2000 Swiss francs (or $) –Costs of PEP per infection prevented: 20’000’000 $ At those odds, you’d probably kill a few with the drugs before saving one from AIDS Not an effective use of health-care resources…

(5) HAART as Prevention See above Can’t really bring that forward while pretending that HAART doesn’t decrease contagiousness.

“Swiss Statement”: Unmet Needs for Research Reasonable data are available for heterosexual transmission, but not in MSM: Different sex practices with trauma might for instance influence infectiousness Conception through unprotected sex: Larger case series are needed - might be obtained in Africa Treatment as prevention: Population-based trials, similar to syndromic treatment for STDs or parasitic diseases, should be envisaged. They face considerable hurdles (ethical, political, financial)

Thank you to… Julio Montaner for the slides of his plenary conference in Toronto (August 2006) Pietro Vernazza

The End

Hogg et al. Unpublished, 2006 Treat all Treat 30% HIV infections per 1000 population

Coûts du traitement Treat all Treat 30% $ Hogg et al. Unpublished, 2006

Costs of HAART Billions de $ Small investment Great savings Lima VD et al. Expanded Access to Highly Active Antiretroviral Therapy: A Powerful Strategy to Curb the HIV Epidemic; JID 2008; volume 198, July 1. Hogg et al. Unpublished, 2006

Recently infected homosexuals Total Population (PHI, )232 Interviewed158 Express an opinion on how they were infected143 « Sure » that source had undetectable viremia 9 « Sure » that source was HIV negative 21 Jin F et al: How homosexual men believe they became infected with HIV. JAIDS 2007; 46: Zero-Risk-Problem (1):

Enquiry in the Swiss HIV Cohort Study: « Do you know cases of transmission where a treated patient with undetectable viremia was involve»? –1 troubling case in Geneva, 1997 Study in the litterature: –None (one possible case in Francfort has been submitted for publication) Zero-Risk-Problem (2):

It is impossible to prove the absence of risk –Let’s say that among 100 sero-discordant couples, there are zero infection after 2 years of observation –Would this still be zero in 1000 couples observed during 10 years? Where is the limite? Guidelines protect those who write them –The politician, or the expert who denies a risk which nevertheless turns out to be real indangers his career. The oppostite mistake has no consequences. –One can never be too prudent (said the concierge) Zero-Risk-Problem (3):

Costs of treatment Billions of $ Small investment Great Savings Hogg et al. Unpublished, 2006

One could go further… Mr. X is HIV+, his wife HIV-, anxious, in vitro fertilization was not successful Non-protected sex during days of each cycle Mrs. X takes one pill of tenofovir per day Will we one day all be like Mrs. X, taking something daily to protect against HIV ?

Quiz Against which other disease that used to be frequent are all the Swiss protected by a drug added to food ?

Effects of iodine deficiency

The Iodine Model: HAART in Food HIVIodine Deficiency Quantity per day 1000 mg100  g

-The doses are 10’000 times higher -Resistance -Toxicity There Are A Few Problems Left To Solve…

Speisesalz mit Jod, Fluor, und Preventivirin Sel de cuisine avec iode, fluor, et préventivirine Pack of salt, bought in Geneva, 27th November 2030 Kitchen salt with iodine, fluorate, and preventivirin

Contents Without treatment: Relation between viremia and contagiousness Haart: Effects on viremia and contagiousness For the individual: Conclusions to draw (or not) The epidemic: possible consequences Background to the “Swiss Statement ”